Opentrons Labworks the creator of robots for analyzing Covid-19 tests

The company has raised $200 million from SoftBank and others.

● Khosla Ventures and Pfizer CEO Jeff Kindler also participated in the round, Bloomberg reported. The company plans to invest in the development of new diagnostic and test production tools and additional laboratories.

● Opentrons Labworks was founded in Brooklyn in 2013 by bioengineers Chiu Chau, Nicholas Wagner, and entrepreneur Will Kenine. In 2014, the company was valued at $ 90 million, according to the publication. Opentrons offers robotic labs for analysis, robotics for medical professionals, and cell engineering in biopharmaceuticals. The company does not disclose its financial results.

● In 2020, Opentrons Labworks tested more than 2 million New Yorkers and established centers in Washington DC and Los Angeles, where they conduct tests for schools for about $1 per child. The company works with partners in other countries of the world.

● Since July 2020, Opentrons has reduced the time it takes to get test results for Covid-19 from 7 to 14 days to 24 hours, and their cost from $ 2,000 to $28. The company's robots were the first to detect the delta mutation of the coronavirus.

● In 2021, Moderna co-founder Professor Robert Langer became the head of the Opentrons Scientific Advisory Board. Joseph Marc Blumenthal says that this could indicate the company's ambitions in the field of vaccine production and drug development.